Growth in children with cystic fibrosis-related diabetes-Reference-Cited by-同舟云学术

Growth in children with cystic fibrosis-related diabetes

Published:2009-11-05 Issue:12 Volume:44 Page:1223-1225
ISSN:8755-6863
Container-title:Pediatric Pulmonology
language:en
Short-container-title:Pediatr. Pulmonol.

Author:

Cheung M.S.,Bridges N.A.,Prasad S.A.,Francis J.,Carr S.B.,Suri R.,Balfour-Lynn I.M.

Publisher

Wiley

Subject

Pulmonary and Respiratory Medicine,Pediatrics, Perinatology and Child Health

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/ppul.21127/fullpdf

Reference11 articles.

1. Glucose tolerance and insulin secretion, morbidity, and death in patients with cystic fibrosis;Bismuth;J Pediatr,2008

2. Long-term effect of insulin treatment in cystic fibrosis-related diabetes;Mohan;Respiration,2008

3. UK Cystic Fibrosis Trust Diabetes Working Group Management of cystic fibrosis related diabetes mellitus 2004 http://www.cftrust.org.uk/aboutcf/publications/consensusdoc/diabetes.pdf

4. New criteria for impaired fasting glucose and screening for diabetes in cystic fibrosis;Mueller-Brandes;Eur Respir J,2005

5. Growth and long-term lung function in cystic fibrosis: a longitudinal study of patients diagnosed by neonatal screening;Assael;Pediatr Pulmonol,2009

Cited by 36 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Screening strategies for glucose tolerance abnormalities and diabetes in people with cystic fibrosis;Diabetes & Metabolism;2023-05

2. Distribution of OGTT-Related Variables in Patients with Cystic Fibrosis from Puberty to Adulthood: An Italian Multicenter Study;Journal of Personalized Medicine;2023-03-03

3. Dépistage des anomalies de la tolérance au glucose et du diabète de mucoviscidose. Position de la Société française de la mucoviscidose (SFM), de la Société francophone du diabète (SFD) et de la Société française d’endocrinologie et diabétologie pédiatrique (SFEDP);Médecine des Maladies Métaboliques;2023-01

4. ISPAD Clinical Practice Consensus Guidelines 2022: Management of cystic fibrosis‐related diabetes in children and adolescents;Pediatric Diabetes;2022-12

5. Cystic Fibrosis-Related Diabetes: Clinical approach and knowledge gaps;Paediatric Respiratory Reviews;2022-10